Sites and patients have complicated views on telehealth in trials. Here’s what the evidence shows about who benefits, who bears the burden, and where the limits are.
- Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
ON-DEMAND WEBINARS
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
In this webinar, panelists discuss how connecting sources of real world data (RWD) to clinical trial enables many benefits, including the ability to supplement data for patients lost to follow up and augment trial data to help explain non-responders and adverse events.
During this presentation, industry experts provide insights on how clinical trial stakeholders can enrich the participants' journeys in harmony with PFDD objectives.
In this webinar, eCOA experts will explore how to implement a BYOD strategy, relevant BYOD regulatory considerations, and where the market is going from here.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Medable ceo 2]( "Letter From The CEO: A New Era Of Drug Development Is Here")
Letter From The CEO: A New Era Of Drug Development Is HereThis letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.
-
![GettyImages-1443965506 doctor clinical trial data monitoring]( "The Strategic Case For RTSM in Phase 1 Trials")
The Strategic Case For RTSM in Phase 1 TrialsPhase 1 trials demand precision and speed. RTSM delivers real-time control over enrollment, dosing, and supply, reducing risk and enabling adaptive strategies that keep timelines on track.
-
![GettyImages-1344606074 data insights]( "Data-Driven Adaptive Trials Enhance Safety, Progress, And Economics")
Data-Driven Adaptive Trials Enhance Safety, Progress, And EconomicsBy offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
-
![GettyImages-1531115888 wearables]( "Guide: How Connected Devices Improve Clinical Trial Data")
Guide: How Connected Devices Improve Clinical Trial DataGain an overview of how and why connected devices provide sponsors and CROs with better clinical trial data, and offer patients much better trial experiences!
-
![Getty-1652511983-supply-chain-management]( "A Custom IRT System Facilitates Precision Medicine Studies")
A Custom IRT System Facilitates Precision Medicine StudiesAs the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.
-
![GettyImages-1180581753-scientists-lab-monitoring-computer-laboratory]( "Digital Health Solution For CRS Detection And Prediction")
Digital Health Solution For CRS Detection And PredictionExplore how digital health technologies offer a data-driven solution to cytokine release syndrome (CRS) monitoring, reducing inpatient care requirements while ensuring patient safety.
-
![iStock-1002126898-graph-tablet-meeting-risks-planning]( "Accelerating Your New Therapies Path To Market With Automation")
Accelerating Your New Therapies Path To Market With AutomationAutomation has become an essential tool for addressing the inefficiencies in traditional clinical trial methodologies, enabling trial teams to instead concentrate on critical tasks such as patient care.
-
![GettyImages-1426935964 DCTs]( "With The Emergence Of DCTs, Do We Really Need A CTMS?")
With The Emergence Of DCTs, Do We Really Need A CTMS?As decentralized trial designs continue to grow in popularity, do sponsors and CROs really need a clinical trial management system? Explore whether CTMS is necessary with the emergence of DCTs.
-
![GettyImages-1491204186 data]( "Guide: Switching To A New EDC System")
Guide: Switching To A New EDC SystemRead to learn five key tips when switching to a new EDC system, including best practices for change management, process and people training, KPIs, and more.
-
![getty-1309275676-flow-of-data]( "Redefining Evidence Generation In Modern Clinical Trials")
Redefining Evidence Generation In Modern Clinical TrialsAs trials continue to digitize, learn how connected sensors, COAs, PROs, and other forms of data will come together to form the evidence of tomorrow.
FROM THE EDITOR
- Telehealth In Clinical Trials: What Sites And Patients Think
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
RECENT NEWSLETTERS
- 03.05.26 -- Is Your Legacy EDC Holding Back AI In Clinical Trials?
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
